MB

Mark K. Bennett

RP Rigel Pharmaceuticals: 16 patents #42 of 184Top 25%
OT Onyx Therapeutics: 14 patents #4 of 49Top 9%
CB Calithera Biosciences: 3 patents #13 of 36Top 40%
PR Proteolix: 1 patents #7 of 12Top 60%
UN Unknown: 1 patents #29,356 of 83,584Top 40%
Overall (All Time): #98,263 of 4,157,543Top 3%
35
Patents All Time

Issued Patents All Time

Showing 25 most recent of 35 patents

Patent #TitleCo-InventorsDate
10940148 Combination therapy with glutaminase inhibitors and immuno-oncology agents Susan Molineaux, Matthew I. Gross, Susan D. Bromley, Francesco Parlati 2021-03-09
RE47954 Combination therapy with peptide epoxyketones Christopher J. Kirk, Susan Demo 2020-04-21
10596222 Combination therapy with peptide epoxyketones Christopher J. Kirk, Susan Demo 2020-03-24
10258619 Combination therapy with glutaminase inhibitors and immuno-oncology agents Susan Molineaux, Matthew I. Gross, Susan D. Bromley, Francesco Parlati 2019-04-16
10195197 Combination therapy with glutaminase inhibitors Matthew I. Gross, Susan D. Bromley, Keith Orford 2019-02-05
9657058 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark S. Smyth +1 more 2017-05-23
9511109 Combination therapy with peptide epoxyketones Christopher J. Kirk, Susan Demo 2016-12-06
9359398 Compounds for immunoproteasome inhibition Kevin D. Shenk, Francesco Parlati 2016-06-07
9040462 In vivo production of cyclic peptides for inhibiting protein-protein interaction James Lorens, Todd Pray, Todd Kinsella 2015-05-26
8895034 Collagen production compound 2014-11-25
8765745 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark S. Smyth +1 more 2014-07-01
8735441 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark S. Smyth +1 more 2014-05-27
8697837 Substrate for Rpn 11 enzymatic activity Francesco Parlati, Monette Aujay 2014-04-15
8609654 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Catherine Sylvain, Mark S. Smyth, Guy J. Laidig +1 more 2013-12-17
8431571 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark S. Smyth +1 more 2013-04-30
8357683 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark S. Smyth +1 more 2013-01-22
8080576 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark S. Smyth +1 more 2011-12-20
8080545 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark S. Smyth +1 more 2011-12-20
7741432 Substrate for Rpn11 enzymatic activity Francesco Parlati, Monette Aujay 2010-06-22
7691852 Compounds for enzyme inhibition Kevin D. Shenk, Francesco Parlati, Han-Jie Zhou, Catherine Sylvain, Mark S. Smyth +1 more 2010-04-06
7604951 Method for identifying compounds that modulate RXR associated processes with IgE production Todd Kinsella, Esteban Masuda, Justin E. Warner, David C. Anderson 2009-10-20
7598050 Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein Esteban Masuda, Todd Kinsella, Justin E. Warner, Taisei Kinoshita, David C. Anderson 2009-10-06
7563585 Methods of assaying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein (TXNL) Esteban Masuda, Todd Kinsella, Justin E. Warner, Taisei Kinoshita, David C. Anderson 2009-07-21
7425418 Compounds that modulate processes associated with IgE production Todd Kinsella, Esteban Masuda, Justin E. Warner, David C. Anderson 2008-09-16
7422867 Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein Esteban Masuda, Todd Kinsella, Justin E. Warner, Taisei Kinoshita, David C. Anderson 2008-09-09